Síntomas, causas y tratamiento de una mesenteritis esclerosante
The term sclerosing mesenteritis refers to an idiopathic, rare, chronic disease characterized by inflammatory and fibrotic changes in the adipose tissue of the mesentery of the intestine. Its etiology is unknown, but it is believed that it may be the result of a non-specific inflammatory response of...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | español |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8056963 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | The term sclerosing mesenteritis refers to an idiopathic, rare, chronic disease characterized by inflammatory and fibrotic changes in the adipose tissue of the mesentery of the intestine. Its etiology is unknown, but it is believed that it may be the result of a non-specific inflammatory response of the mesentery to an allergic, chemical, thermal, infectious, autoimmune or surgical attack, although there is no scientific evidence to support this hypothesis. This article describes and compares different literatures on Symptoms, causes and treatment of sclerosing mesenteritis. To do this, this information is collected from different bibliographic sources acquired from databases (SCOPUS, PubMed, Cochrane Library, Google Scholar), assessing the quality and veracity of the information collected, as well as the timeliness of the content. The two case studies presented here confirm that this condition occurs mainly in men and that the diagnosis to determine it can be confusing due to the similarity of other pathologies, which leads to the performance of multiple studies (including laparoscopic procedures). In the context of treatment, unless there is an intestinal obstruction where a surgical procedure is required (diversions, partial resections, or colostomy), there is no specific treatment, although there is research that suggests immunosuppressive and immunomodulatory drugs. |
|---|